✦ LIBER ✦

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

✍ Scribed by Jisun Kim, Wonshik Han, Hyeong-Gon Moon, Soo K Ahn, Hee-Chul Shin, Jee-Man You, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Hye R Koo, Jung M Chang, Nariya Cho, Woo K Moon, Dong-Young Noh

Book ID: 118726981
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 68 KB
Volume: 14
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3353

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast density change as a predictive su

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

✍ Jisun Kim, Wonshik Han, Hyeong-Gon Moon, Soo Kyung Ahn, Hee-Chul Shin, Jee-Man Y 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 198 KB

310 Breast Density Change as a Predictiv

310 Breast Density Change as a Predictive Surrogate of Adjuvant Anti-estrogen Therapy Response in Estrogen Receptor Positive Breast Cancer

✍ J.S. Kim; W. Han; J.M. You; H.C. Shin; S.K. Ahn; H.G. Moon; D.Y. Noh; N. Cho; W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Immunohistochemical evaluation of hormon

Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer

✍ Hiroko Yamashita; Yoshiaki Ando; Mariko Nishio; Zhenhuan Zhang; Maho Hamaguchi; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 894 KB

PET-based estradiol challenge as a predi

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

✍ Farrokh Dehdashti; Joanne E. Mortimer; Kathryn Trinkaus; Michael J. Naughton; Ma 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 221 KB

Interpreting breast international group

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

CMF versus goserelin as adjuvant therapy

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: A randomised trial (GABG trial IV-A-93)

✍ Gunter von Minckwitz; Erika Graf; Matthias Geberth; Wolfgang Eiermann; Walter Jo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 321 KB